Recurrence of methotrexate-induced leukoencephalopathy after methotrexate rechallenge: A case report and literature review

Methotrexate (MTX) is potent chemotherapeutic agent, often administered intrathecally to treat or prevent central nervous system involvement in lymphomas and leukemias, particularly T-cell lymphoblastic leukemia (T-LBL). MTX has been linked to adverse neurologic effects that mimic acute stroke, incl...

Descripción completa

Detalles Bibliográficos
Autores principales: AlKawi, Ammar, Hanbali, Amr, Haj Aissa, Naser, Mufti, Mohammad Alaa, Abdul Rab, Saleha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793162/
https://www.ncbi.nlm.nih.gov/pubmed/36582751
http://dx.doi.org/10.1016/j.radcr.2022.11.057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793162/
https://www.ncbi.nlm.nih.gov/pubmed/36582751
http://dx.doi.org/10.1016/j.radcr.2022.11.057

Ejemplares similares